TY - JOUR AU - Dai, Z. AU - Zheng, R. S. AU - Zou, X. N. PY - 2012 DA - 2012// TI - Analysis and prediction of colorectal cancer incidence trend in China JO - Zhonghua Yu Fang Yi Xue Za Zhi VL - 46 ID - Dai2012 ER - TY - JOUR AU - Chen, W. AU - Zheng, R. AU - Baade, P. D. PY - 2016 DA - 2016// TI - Cancer statistics in China, 2015 JO - CA Cancer J Clin VL - 66 UR - https://doi.org/10.3322/caac.21338 DO - 10.3322/caac.21338 ID - Chen2016 ER - TY - JOUR AU - Liu, S. AU - Zheng, R. AU - Zhang, M. PY - 2015 DA - 2015// TI - Incidence and mortality of colorectal cancer in China, 2011 JO - Chin J Cancer Res VL - 27 UR - https://doi.org/10.1186/s40880-015-0023-9 DO - 10.1186/s40880-015-0023-9 ID - Liu2015 ER - TY - JOUR AU - Wang, Z. Q. AU - Zhang, D. S. AU - Xu, N. PY - 2016 DA - 2016// TI - Phase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancer JO - Chin J Cancer VL - 35 UR - https://doi.org/10.1186/s40880-015-0061-3 DO - 10.1186/s40880-015-0061-3 ID - Wang2016 ER - TY - JOUR AU - Weiss, L. AU - Grundmann, E. AU - Torhorst, J. PY - 1986 DA - 1986// TI - Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies JO - J Pathol VL - 150 UR - https://doi.org/10.1002/path.1711500308 DO - 10.1002/path.1711500308 ID - Weiss1986 ER - TY - JOUR AU - Lin, G. N. AU - Liu, P. P. AU - Liu, D. Y. PY - 2016 DA - 2016// TI - Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy JO - Chin J Cancer VL - 35 UR - https://doi.org/10.1186/s40880-015-0063-1 DO - 10.1186/s40880-015-0063-1 ID - Lin2016 ER - TY - JOUR AU - Abdalla, E. K. AU - Vauthey, J. N. AU - Ellis, L. M. PY - 2004 DA - 2004// TI - Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases JO - Ann Surg VL - 239 UR - https://doi.org/10.1097/01.sla.0000128305.90650.71 DO - 10.1097/01.sla.0000128305.90650.71 ID - Abdalla2004 ER - TY - JOUR AU - Adam, R. AU - Pascal, G. AU - Castaing, D. PY - 2004 DA - 2004// TI - Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? JO - Ann Surg VL - 240 UR - https://doi.org/10.1097/01.sla.0000145964.08365.01 DO - 10.1097/01.sla.0000145964.08365.01 ID - Adam2004 ER - TY - JOUR AU - Power, D. G. AU - Kemeny, N. E. PY - 2010 DA - 2010// TI - Role of adjuvant therapy after resection of colorectal cancer liver metastases JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.26.9340 DO - 10.1200/JCO.2009.26.9340 ID - Power2010 ER - TY - JOUR AU - Ihnat, P. AU - Vavra, P. AU - Zonca, P. PY - 2015 DA - 2015// TI - Treatment strategies for colorectal carcinoma with synchronous liver metastases: which way to go? JO - World J Gastroenterol VL - 21 UR - https://doi.org/10.3748/wjg.v21.i22.7014 DO - 10.3748/wjg.v21.i22.7014 ID - Ihnat2015 ER - TY - JOUR AU - Kopetz, S. AU - Chang, G. J. AU - Overman, M. J. PY - 2009 DA - 2009// TI - Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.20.5278 DO - 10.1200/JCO.2008.20.5278 ID - Kopetz2009 ER - TY - JOUR AU - Nordlinger, B. AU - Sorbye, H. AU - Glimelius, B. PY - 2013 DA - 2013// TI - Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70447-9 DO - 10.1016/S1470-2045(13)70447-9 ID - Nordlinger2013 ER - TY - JOUR AU - Brandi, G. AU - Lorenzo, S. AU - Nannini, M. PY - 2016 DA - 2016// TI - Adjuvant chemotherapy for resected colorectal cancer metastases: literature review and meta-analysis JO - World J Gastroenterol VL - 22 UR - https://doi.org/10.3748/wjg.v22.i2.519 DO - 10.3748/wjg.v22.i2.519 ID - Brandi2016 ER - TY - JOUR AU - Eisenhauer, E. A. AU - Therasse, P. AU - Bogaerts, J. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER - TY - JOUR AU - Saltz, L. B. AU - Clarke, S. AU - Diaz-Rubio, E. PY - 2008 DA - 2008// TI - Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.14.9930 DO - 10.1200/JCO.2007.14.9930 ID - Saltz2008 ER - TY - JOUR AU - Rubbia-Brandt, L. AU - Giostra, E. AU - Brezault, C. PY - 2007 DA - 2007// TI - Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery JO - Ann Oncol VL - 18 UR - https://doi.org/10.1093/annonc/mdl386 DO - 10.1093/annonc/mdl386 ID - Rubbia-Brandt2007 ER - TY - JOUR AU - Blazer, D. R. AU - Kishi, Y. AU - Maru, D. M. PY - 2008 DA - 2008// TI - Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2008.17.5299 DO - 10.1200/JCO.2008.17.5299 ID - Blazer2008 ER - TY - JOUR AU - Kuerer, H. M. AU - Newman, L. A. AU - Smith, T. L. PY - 1999 DA - 1999// TI - Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy JO - J Clin Oncol VL - 17 UR - https://doi.org/10.1200/JCO.1999.17.2.460 DO - 10.1200/JCO.1999.17.2.460 ID - Kuerer1999 ER - TY - JOUR AU - Ajani, J. A. AU - Mansfield, P. F. AU - Janjan, N. PY - 2004 DA - 2004// TI - Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.01.015 DO - 10.1200/JCO.2004.01.015 ID - Ajani2004 ER - TY - JOUR AU - Mandard, A. M. AU - Dalibard, F. AU - Mandard, J. C. PY - 1994 DA - 1994// TI - Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma JO - Clinicopathologic correlations. Cancer-am Cancer Soc. VL - 73 ID - Mandard1994 ER - TY - JOUR AU - Swisher, S. G. AU - Hofstetter, W. AU - Wu, T. T. PY - 2005 DA - 2005// TI - Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT) JO - Ann Surg. VL - 241 UR - https://doi.org/10.1097/01.sla.0000161983.82345.85 DO - 10.1097/01.sla.0000161983.82345.85 ID - Swisher2005 ER - TY - JOUR AU - Chun, Y. S. AU - Cooper, H. S. AU - Cohen, S. J. PY - 2011 DA - 2011// TI - Significance of pathologic response to preoperative therapy in pancreatic cancer JO - Ann Surg Oncol VL - 18 UR - https://doi.org/10.1245/s10434-011-2086-4 DO - 10.1245/s10434-011-2086-4 ID - Chun2011 ER - TY - JOUR AU - Kishi, Y. AU - Zorzi, D. AU - Contreras, C. M. PY - 2010 DA - 2010// TI - Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases JO - Ann Surg Oncol VL - 17 UR - https://doi.org/10.1245/s10434-010-1166-1 DO - 10.1245/s10434-010-1166-1 ID - Kishi2010 ER - TY - JOUR AU - Klinger, M. AU - Tamandl, D. AU - Eipeldauer, S. PY - 2010 DA - 2010// TI - Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX JO - Ann Surg Oncol VL - 17 UR - https://doi.org/10.1245/s10434-010-0972-9 DO - 10.1245/s10434-010-0972-9 ID - Klinger2010 ER - TY - JOUR AU - Carrasco, J. AU - Gizzi, M. AU - Pairet, G. PY - 2015 DA - 2015// TI - Pathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backbone JO - Br J Cancer VL - 113 UR - https://doi.org/10.1038/bjc.2015.321 DO - 10.1038/bjc.2015.321 ID - Carrasco2015 ER - TY - JOUR AU - Stremitzer, S. AU - Stift, J. AU - Singh, J. PY - 2015 DA - 2015// TI - Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases JO - Eur J Surg Oncol VL - 41 UR - https://doi.org/10.1016/j.ejso.2015.03.223 DO - 10.1016/j.ejso.2015.03.223 ID - Stremitzer2015 ER - TY - JOUR AU - Holch, J. W. AU - Ricard, I. AU - Stintzing, S. PY - 2017 DA - 2017// TI - The relevance of primary tumour location in patients with metastatic colorectal cancer: a meta-analysis of first-line clinical trials JO - Eur J Cancer VL - 70 UR - https://doi.org/10.1016/j.ejca.2016.10.007 DO - 10.1016/j.ejca.2016.10.007 ID - Holch2017 ER - TY - JOUR AU - Sunakawa, Y. AU - Ichikawa, W. AU - Tsuji, A. PY - 2016 DA - 2016// TI - Prognostic impact of primary tumor location on clinical outcomes of metastatic colorectal cancer treated with cetuximab plus oxaliplatin-based chemotherapy: a subgroup analysis of the JACCRO CC-05/06 trials JO - Clin Colorectal Cancer VL - 16 UR - https://doi.org/10.1016/j.clcc.2016.09.010 DO - 10.1016/j.clcc.2016.09.010 ID - Sunakawa2016 ER - TY - JOUR AU - Wang, F. AU - Bai, L. AU - Liu, T. S. PY - 2015 DA - 2015// TI - Right-sided colon cancer and left-sided colorectal cancers respond differently to cetuximab JO - Chin J Cancer VL - 34 ID - Wang2015 ER - TY - JOUR AU - Gruenberger, T. AU - Arnold, D. AU - Rubbia-Brandt, L. PY - 2012 DA - 2012// TI - Pathologic response to bevacizumab-containing chemotherapy in patients with colorectal liver metastases and its correlation with survival JO - Surg Oncol VL - 21 UR - https://doi.org/10.1016/j.suronc.2012.07.003 DO - 10.1016/j.suronc.2012.07.003 ID - Gruenberger2012 ER -